Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Intellipharmaceutics (IPCI) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 81,910
  • Shares Outstanding, K 28,750
  • Annual Sales, $ 4,090 K
  • Annual Income, $ -7,440 K
  • 36-Month Beta 0.98
  • Price/Sales N/A
  • Price/Book 44.52

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.44 +14.75%
on 11/04/16
3.35 -16.42%
on 11/25/16
+0.12 (+4.48%)
since 11/02/16
3-Month
1.73 +61.85%
on 09/15/16
3.35 -16.42%
on 11/25/16
+1.03 (+58.19%)
since 09/02/16
52-Week
1.41 +98.58%
on 06/14/16
3.35 -16.42%
on 11/25/16
+0.46 (+19.66%)
since 12/02/15

Most Recent Stories

More News
Intellipharmaceutics to Present at the LD Micro Main Event

Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and...

Intellipharmaceutics Submits NDA for Pain Treatment Rexista

Intellipharmaceutics International Inc. (IPCI) announced that it has filed a new drug application (NDA) with the FDA for Rexista.

IntelliPharmaCeutics (IPCI) Jumps: Stock Adds 5% in Session

IntelliPharmaCeutics International Inc. (IPCI) shares rose 5% in the last trading session.

How These Healthcare Stocks are Faring? -- Alkermes, Adamis Pharma, BioScrip, and IntelliPharmaCeutics

Stock-Callers.com has initiated coverage on the following equities: Alkermes PLC (NASDAQ: ALKS), Adamis Pharmaceuticals Corp. (NASDAQ: ADMP), BioScrip Inc. (NASDAQ: BIOS), and IntelliPharmaCeutics International...

Will IntelliPharmaCeutics (IPCI) Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in IntelliPharmaCeutics Intl Inc (IPCI).

Intellipharmaceutics to Present at Dawson James Securities Growth Stock Conference

Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and...

Intellipharmaceutics Announces Third Quarter 2016 Results

Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and...

IntelliPharmaCeutics (IPCI) Jumps: Stock Moves 5.4% Higher

IntelliPharmaCeutics International Inc. (IPCI) saw its shares climb above 5% in the last trading session.

Intellipharmaceutics Signs an Exclusive License and Commercial Supply Agreement with Mallinckrodt

Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and...

IIROC Trade Resumption - Intellipharmaceutics International Inc.

Trading resumes in:

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Intellipharmaceutics International Inc. is engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Its products include Effexor XR and Protonix. The Company offers products in different stages of development in therapeutic areas, including...

See More

Support & Resistance

2nd Resistance Point 2.98
1st Resistance Point 2.89
Last Price 2.80
1st Support Level 2.71
2nd Support Level 2.62

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.